Back to top
more

GE HealthCare Technologies Inc. (GEHC)

(Delayed Data from NSDQ)

$83.40 USD

83.40
1,856,120

+0.67 (0.81%)

Updated May 10, 2024 04:00 PM ET

After-Market: $83.37 -0.03 (-0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 42% (146 out of 251)

Industry: Medical Info Systems

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

GE HealthCare Technologies Inc. (GEHC) Is a Trending Stock: Facts to Know Before Betting on It

by Zacks Equity Research

GE HealthCare (GEHC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

GE HealthCare (GEHC) Unveils Head-Only MR Scanner SIGNA MAGNUS

by Zacks Equity Research

GE HealthCare's (GEHC) new SIGNA MAGNUS can delve deep into the brain's microstructure, microvasculature and function, providing researchers with a clearer picture of neurological diseases and disorders.

GE Healthcare's (GEHC) Revolution RT to Aid Cancer Treatment

by Zacks Equity Research

GE Healthcare (GEHC) unveils Revolution RT, along with other upgrades, from its portfolio during the ESTRO 2024 Congress.

Stock Market News for May 1, 2024

by Zacks Equity Research

U.S. stock markets tumbled Tuesday, closing sharply lower.

GE HealthCare (GEHC) Q1 Earnings In Line, Sales Volume Decline

by Zacks Equity Research

GE HealthCare's (GEHC) first-quarter results witness declining segmental revenues in imaging, ultrasound and patient care. The bottom line improves on better pricing.

GE HealthCare (GEHC) Reports Q1 Earnings: What Key Metrics Have to Say

by Zacks Equity Research

While the top- and bottom-line numbers for GE HealthCare (GEHC) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

GE HealthCare Technologies (GEHC) Meets Q1 Earnings Estimates

by Zacks Equity Research

GE HealthCare (GEHC) delivered earnings and revenue surprises of 0% and 3.33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Indrajit Bandyopadhyay headshot

What's in Store for These 5 Medical Device Stocks in Q1 Earnings?

by Indrajit Bandyopadhyay

Here is a sneak peek into how the five medical device stocks, SYK, GEHC, ECL, NARI and MMSI, might fare in their quarterly results slated to be released tomorrow.

Rising Demand Likely to Aid GE HealthCare's (GEHC) Q1 Earnings

by Zacks Equity Research

GE HealthCare's (GEHC) first-quarter results are expected to report strong organic revenue growth, banking on balanced segmental performance driven by consistent NPIs and growing customer demand.

GE HealthCare (GEHC) Is Considered a Good Investment by Brokers: Is That True?

by Zacks Equity Research

According to the average brokerage recommendation (ABR), one should invest in GE HealthCare (GEHC). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

GE HealthCare Technologies (GEHC) Laps the Stock Market: Here's Why

by Zacks Equity Research

GE HealthCare Technologies (GEHC) concluded the recent trading session at $86.21, signifying a +1.96% move from its prior day's close.

GE HealthCare's (GEHC) New Tie-Up to Boost Patient Outcomes

by Zacks Equity Research

GE HealthCare's (GEHC) latest partnership is likely to benefit global healthcare systems by enhancing Elekta's RT offerings with its MIM Software medical imaging management solutions.

Here's Why GE HealthCare Technologies (GEHC) Gained But Lagged the Market Today

by Zacks Equity Research

GE HealthCare Technologies (GEHC) reachead $84.55 at the closing of the latest trading day, reflecting a +0.07% change compared to its last close.

GE HealthCare's (GEHC) Voluson to Aid Women's Health Imaging

by Zacks Equity Research

GE HealthCare (GEHC) announces its latest AI-powered Voluson Signature 20 and 18 ultrasound systems, which are likely to provide effective and efficient care for conditions impacting women's health.

Investors Heavily Search GE HealthCare Technologies Inc. (GEHC): Here is What You Need to Know

by Zacks Equity Research

Zacks.com users have recently been watching GE HealthCare (GEHC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

GE HealthCare (GEHC), RSNA Unite to Aid Breast Cancer Imaging

by Zacks Equity Research

GE HealthCare (GEHC) and RSNA collaborate to provide radiologists at Muhimbili National Hospital a test mammography technology and advanced imaging training to aid in the treatment of breast cancer.

GE HealthCare Technologies (GEHC) Stock Moves -0.17%: What You Should Know

by Zacks Equity Research

In the closing of the recent trading day, GE HealthCare Technologies (GEHC) stood at $86.13, denoting a -0.17% change from the preceding trading day.

GE HealthCare (GEHC) to Showcase Enhanced Breast Cancer Imaging

by Zacks Equity Research

GE HealthCare's (GEHC) latest breast cancer detection technology is likely to enhance the detection and diagnosis of breast cancer and improve patient outcomes.

Medtronic's (MDT) Sphere-360 PFA Study Outcome Favorable

by Zacks Equity Research

Medtronic's (MDT) Sphere-360 catheter is designed to simplify the atrial fibrillation process while increasing efficiency and giving long-lasting lesions.

Here's Why GE HealthCare Technologies (GEHC) Fell More Than Broader Market

by Zacks Equity Research

In the most recent trading session, GE HealthCare Technologies (GEHC) closed at $87.71, indicating a -0.86% shift from the previous trading day.

iRhythm Technologies (IRTC) Surges 4.2%: Is This an Indication of Further Gains?

by Zacks Equity Research

iRhythm Technologies (IRTC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

GE HealthCare's (GEHC) New Launch to Enhance Cardiac Care

by Zacks Equity Research

GE HealthCare's (GEHC) latest offering is likely to expand access to cardiac care by enabling more medical professionals to be able to capture cardiac images.

Wall Street Analysts See GE HealthCare (GEHC) as a Buy: Should You Invest?

by Zacks Equity Research

Based on the average brokerage recommendation (ABR), GE HealthCare (GEHC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

GE HealthCare's (GEHC) PVA to Aid in Capturing Prostate Volume

by Zacks Equity Research

GE HealthCare (GEHC) announces the launch of Prostate Volume Assist AI-enabled urology software feature, which is likely to boost prostate imaging, capture prostate volume and increase workflow.